Pediatric Infection and Vaccine

  • 제22권3호
  • /
  • Pages.194-200
  • /
  • 2015
  • /
  • 2384-1079(pISSN)
  • /
  • 2384-1087(eISSN)
대한소아감염학회 (The Korean Society of Pediatric Infectious Diseases)
권호 표지
DOI QR코드

DOI QR Code

소아 요로감염의 원인 Escherichia coli 균의 계통 분류와 독성인자 분석

Phylogenetic Groups and Virulence Factors of Escherichia coli Causing Urinary Tract Infection in Children

  • 김지목 (충남대학교 의과대학 소아과학교실) ;
  • 조은영 (충남대학교 의과대학 소아과학교실) ;
  • 이재호 (충남대학교 의과대학 소아과학교실)
  • Kim, Ji Mok (Department of Pediatrics, Chungnam National University School of Medicine) ;
  • Cho, Eun Young (Department of Pediatrics, Chungnam National University School of Medicine) ;
  • Lee, Jae Ho (Department of Pediatrics, Chungnam National University School of Medicine)
  • 투고 : 2015.09.01
  • 심사 : 2015.10.06
  • 발행 : 2015.12.25
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

목적: 요로감염은 소아에서 흔한 세균 감염이며, Escherichia coli가 주요 원인균이다. 본 연구는 우리나라에서 소아 요로감염을 일으키는 E. coli의 계통 분류와 독성인자를 분석하고자 하였다. 방법: 2010년 10월부터 2013년 4월까지 요로감염으로 입원한 33명의 소아 환자로부터 검출된 E. coli균주를 대상으로 하였다. 중합효소연쇄반응을 통해 E. coli의 계통 분류 및 5가지 독성인자(fimH, sfa, papA, hylA, and cnf1)를 조사하였다. E. coli의 분자유전학적 특징을 환자의 임상적 진단과 동반된 방광요관 역류에 따라 분석하였다. 결과: 대부분의 요로병원성 E. coli 는 계통 분류에서 B2군(84.8%)에 속했으며, 나머지는 모두 D군(15.2%)에 해당되었다. 독성인자는 fimH (100%), sfa (100%), hylA (63.6%), cnfI (63.6%), 그리고 papA (36.4%)의 분포를 보였다. 임상 진단에 따른 계통 분류에서 급성 신우신염의 경우 B2군이 92.3%, D군이 7.7%를 나타냈으며, 방광염에서는 B2군에서 57.1%, D2군은 42.9%였다. 독성인자는 양 군에서 비슷하게 분포하였다. 급성 신우신염에서 방광요관 역류의 유무에 따른 계통 분류의 분포에는 차이가 없었으나, 독성인자의 경우 papA 유전자가 방광요관 역류가 동반되지 않은 군에서보다 방광요관 역류 군에서 적게 나타났다(43.8% vs. 20.0%, P=0.399). 결론: 본 연구는 국내 소아 요로감염의 원인 E. coli 균주의 분자유전학적 역학 자료를 제시하였으며, 이 결과는 향후 소아 요로감염의 발생 기전을 이해하는 데 기초가 될 것으로 생각된다.

Purpose: Urinary tract infection (UTI) is a common bacterial infection in children and Escherichia coli is a predominant pathogen. The purpose of this study is to evaluate phylogenetic groups and virulence factors of E. coli causing UTI in children in Korea. Methods: From October 2010 to April 2013, urinary E. coli strains were isolated from the 33 pediatric patients of UTI. Multiplex polymerase chain reactions were performed to evaluate the phylogenetic groups and 5 virulence factor genes (fimH, sfa, papA, hylA, and cnf1) of E. coli. Distribution of molecular characteristics of E. coli was analyzed by clinical diagnosis and accompanying vesicoureteral reflux (VUR). Results: Most (84.8%) uropathogenic E. coli were belonged to phylogenetics group B2 and the others (15.2%) were belonged to group D. The virulence factors were distributed as: fimH (100%), sfa (100%), hylA (63.6%), cnfI (63.6%), and papA (36.4%). According to clinical diagnosis, phylogenetic distribution of E. coli strain was 92.3% of B2 and 7.7% of D in acute pyelonephritis and 57.1% of B2 and 42.9% of D in cystitis. Distribution of virulence factors was similar in both groups. In patients with acute pyelonephritis, phylogenetic distribution was similar in VUR and non-VUR group, but proportion of papA genes were lower in VUR group than that of non-VUR group (43.8% vs. 20.0%, P=0.399). Conclusions: This study provides current epidemiologic molecular data of E. coli causing pediatric UTI in Korea and will be a fundamental for understanding the pathogenesis of pediatric UTI.

키워드

참고문헌

  1. Shaikh N, Morone NE, Bost JE, Farrell MH. Prevalence of urinary tract infection in childhood: a meta-analysis. Pediatr Infect Dis J 2008;27:302-8. https://doi.org/10.1097/INF.0b013e31815e4122
  2. Roberts KB, Akintemi OB. The epidemiology and clinical presentation of urinary tract infections in children younger than 2 years of age. Pediatr Ann 1999;28:644-9. https://doi.org/10.3928/0090-4481-19991001-08
  3. Faust WC, Diaz M, Pohl HG. Incidence of post-pyelonephritic renal scarring: a meta-analysis of the dimercapto-succinic acid literature. J Urol 2009;181:290-8.
  4. Park YS. Renal scar formation after urinary tract infection in children. Korean J Pediatr 2012;55:367-70. https://doi.org/10.3345/kjp.2012.55.10.367
  5. Lee YJ, Lee JH, Park YS. Risk factors for renal scar formation in infants with first episode of acute pyelonephritis: a prospective clinical study. J Urol 2012;187:1032-6. https://doi.org/10.1016/j.juro.2011.10.164
  6. Pecile P, Miorin E, Romanello C, Vidal E, Contardo M, Valent F, et al. Age-related renal parenchymal lesions in children with first febrile urinary tract infections. Pediatrics 2009;124:23-9. https://doi.org/10.1542/peds.2008-1192
  7. Jung HJ, Aum JA, Jung SJ, Huh JW. Different characteristic between Escherichea coli and non-Escherichea coli urinary tract infection. Korean J Pediatr 2007;50:457-61. https://doi.org/10.3345/kjp.2007.50.5.457
  8. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002;113: 5-13.
  9. Bien J, Sokolova O, Bozko P. Role of uropathogenic Escherichia coli virulence factors in development of urinary tract infection and kidney damage. Int J Nephrol 2012;2012:681473.
  10. Bonacorsi S, Houdouin V, Mariani-Kurkdjian P, Mahjoub-Messai F, Bingen E. Comparative prevalence of virulence factors in Escherichia coli causing urinary tract infection in male infants with and without bacteremia. J Clin Microbiol 2006;44:1156-8. https://doi.org/10.1128/JCM.44.3.1156-1158.2006
  11. Lee DG, Cho JJ, Park HK, Kim DK, Kim JI, Chang SG, et al. Preventive effects of hyaluronic acid on Escherichia coli -induced urinary tract infection in rat. Urology 2010;75:949-54. https://doi.org/10.1016/j.urology.2009.05.047
  12. Chiou YY, Chen MJ, Chiu NT, Lin CY, Tseng CC. Bacterial virulence factors are associated with occurrence of acute pyelonephritis but not renal scarring. J Urol 2010;184:2098-102. https://doi.org/10.1016/j.juro.2010.06.135
  13. Billips BK, Forrestal SG, Rycyk MT, Johnson JR, Klumpp DJ, Schaeffer AJ. Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli . Infect Immun 2007;75:5353-60. https://doi.org/10.1128/IAI.00922-07
  14. Schilling JD, Mulvey MA, Hultgren SJ. Dynamic interactions between host and pathogen during acute urinary tract infections. Urology 2001;57:56-61.
  15. Song J, Abraham S. Innate and adaptive immune responses in the urinary tract. Eur J Clin Invest 2008;38:21-8. https://doi.org/10.1111/j.1365-2362.2008.02005.x
  16. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000;66:4555-8. https://doi.org/10.1128/AEM.66.10.4555-4558.2000
  17. Tarchouna M, Ferjani A, Ben-Selma W, Boukadida J. Distribution of uropathogenic virulence genes in Escherichia coli isolated from patients with urinary tract infection. Int J Infect Dis 2013;17:e450-3. https://doi.org/10.1016/j.ijid.2013.01.025
  18. Newman TB, Bernzweig JA, Takayama JI, Finch SA, Wasserman RC, Pantell RH. Urine testing and urinary tract infections in febrile infants seen in office settings: the Pediatric Research in Office Settings' Febrile Infant Study. Arch Pediatr Adolesc Med 2002;156:44-54. https://doi.org/10.1001/archpedi.156.1.44
  19. Mak RH, Kuo HJ. Pathogenesis of urinary tract infection: an update. Curr Opin Pediatr 2006;18:148-52. https://doi.org/10.1097/01.mop.0000193276.39495.0d
  20. Johnson JR, Owens K, Gajewski A, Kuskowski MA. Bacterial characteristics in relation to clinical source of Escherichia coli isolates from women with acute cystitis or pyelonephritis and uninfected women. J Clin Microbiol 2005;43:6064-72. https://doi.org/10.1128/JCM.43.12.6064-6072.2005
  21. Tiba MR, Yano T, Leite Dda S. Genotypic characterization of virulence factors in Escherichia coli strains from patients with cystitis. Rev Inst Med Trop Sao Paulo 2008;50:255-60. https://doi.org/10.1590/S0036-46652008000500001
  22. Houdouin V, Bonacorsi S, Mahjoub-Messai F, Mariani- Kurkdjian P, Bidet P, Sebag G, et al. Phylogenetic groups and virulence factors of Escherichia coli strains causing pyelonephritis in children with and without urinary tract abnormalities. Clin Microbiol Infect 2007;13:740-2. https://doi.org/10.1111/j.1469-0691.2007.01748.x
  23. Brauner A, Jacobson SH, Kuhn I. Urinary Escherichia coli causing recurrent infections--a prospective follow-up of biochemical phenotypes. Clin Nephrol 1992;38:318-23.
  24. Foxman B, Gillespie B, Koopman J, Zhang L, Palin K, Tallman P, et al. Risk factors for second urinary tract infection among college women. Am J Epidemiol 2000;151:1194-205. https://doi.org/10.1093/oxfordjournals.aje.a010170
  25. Ikahelmo R, Siitonen A, Heiskanen T, Karkkainen U, Kuosmanen P, Lipponen P, et al. Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women. Clin Infect Dis 1996;22:91-9. https://doi.org/10.1093/clinids/22.1.91

피인용 문헌

  1. ST131 in urinary tract infections in children vol.60, pp.7, 2017, https://doi.org/10.3345/kjp.2017.60.7.221